Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 12028-12035
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.12028
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.12028
Table 3 Distribution of testicular neuroendocrine tumor immunohistochemical results in 132 cases
| Marker | Number of patients | Positive cases | Rate |
| Cytokeratin | 29 | 27 | 93.10% |
| Chromogranin | 59 | 59 | 100% |
| Synaptophysin | 45 | 45 | 100% |
| PLAP | 20 | 0 | 0 |
| Serotonin | 15 | 13 | 86.67% |
| NSE | 14 | 14 | 100% |
| p53 | 11 | 0 | 0 |
| CD56 | 7 | 7 | 100% |
| Vimentin | 6 | 5 | 83.30% |
| Inhibin | 4 | 0 | 0 |
| TTF 1 | 3 | 1 | 33.33% |
| AFP | 2 | 0 | 0 |
- Citation: Xiao T, Luo LH, Guo LF, Wang LQ, Feng L. Primary testicular neuroendocrine tumor with liver lymph node metastasis: A case report and review of the literature. World J Clin Cases 2022; 10(32): 12028-12035
- URL: https://www.wjgnet.com/2307-8960/full/v10/i32/12028.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i32.12028